ELZANOR 12.5/500MG TAB

ELZANOR 12.5/500MG TAB is a combination medication containing Empagliflozin 12.5mg and Metformin Hydrochloride 500mg. This dual-action formulation is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Empagliflozin works by increasing glucose excretion through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Suitable for patients requiring enhanced glycemic management, ELZANOR offers convenient combination therapy in a single tablet, helping reduce pill burden while supporting better diabetes control.